Published in Presse Med on October 13, 1951
Serum enzymes in the physiopathology of muscle. Ann N Y Acad Sci (1958) 1.64
[Radioactive sodium Na24 and cerebrospinal fluid; applications to the diagnosis of tuberculous meningitis and spinal cord compression]. Rev Neurol (Paris) (1951) 1.48
Biochemical study of muscle in progressive muscular dystrophy. J Clin Invest (1954) 1.28
[Elevation of the serum aldolase level; biochemical test in myopathy]. Sem Hop (1953) 1.24
Glycogenolytic enzymes in human progressive muscular dystrophy. Am J Phys Med (1955) 1.23
[Enzyme activity in human muscles; research on comparative biochemistry in normal and myopathic men, and in rats]. Clin Chim Acta (1957) 1.07
SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN: CHIMERISM, INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS. Blood (1965) 1.07
[Muscle lactic dehydrogenase in myopathy: apparent persistence of the fetal type]. C R Hebd Seances Acad Sci (1962) 1.04
[The enzymatic defect of benign fructosuria]. Enzymol Biol Clin (Basel) (1963) 0.99
[Cancer of the thyroid treated with radioactive iodine; termination by acute leukemia after an important amelioration]. Bull Assoc Fr Etud Cancer (1953) 0.98
The molecular turnover of muscle aldolase. J Biol Chem (1960) 0.98
[Studies on the growth of BCG bacillus in the presence of radioactive phosphorus]. Ann Inst Pasteur (Paris) (1953) 0.96
[Nanism caused by incomplete hypothyroidism]. Sem Hop (1957) 0.93
Genetics of haemochromatosis. Ann Hum Genet (1958) 0.92
[Not Available]. Rev Fr Etud Clin Biol (1957) 0.91
[Metabolism of iron in the descendants of patients with bronze cirrhosis]. Bull Mem Soc Med Hop Paris (1952) 0.91
[Incorporation of radionitrogen-labeled glycine into myosin; role of muscle atrophy and topography]. Bull Soc Chim Biol (Paris) (1953) 0.91
ANOMALY OF ALDOLASE IN PRIMARY LIVER CANCER. Nature (1963) 0.90
[Determination of the time of renewal of natural thyroid hormone labelled with radioiodine in rabbit and in man]. C R Seances Soc Biol Fil (1951) 0.90
[Biological anomalies in the apparently healthy transmitters of muscular dystrophy]. Rev Can Biol (1963) 0.87
[CURRENT DATA ON THE RISKS FOR THE EMBRYO, FETUS AND CHILD OF MEDICAL RADIOLOGY. DESCRIPTION OF MEASURES ALREADY CARRIED OUT TO AVOID THEM. SUGGESTIONS ON MEASURES TO BE TAKEN]. Rev Hyg Med Soc (1963) 0.86
[Plasmatic iron & synthesis of hemoglobin]. Sang (1958) 0.85
[Results of examination of 85 cases of cancer of the thyroid with radioactive iodine]. J Radiol Electrol Arch Electr Medicale (1951) 0.85
[Protein anabolism of the muscle atrophied in period of growth]. C R Seances Soc Biol Fil (1950) 0.85
[Not Available]. Bull Assoc Fr Etud Cancer (1957) 0.84
[The length of stay in the plasma of aldolase in the rabbit: study aided by aldolase labelled with radioactive iodine]. Rev Fr Etud Clin Biol (1962) 0.84
THYROIDAL IODOPROTEINS IN PATIENTS WITH GOITROUS HYPOTHYROIDISM. J Clin Endocrinol Metab (1964) 0.84
LACTIC DEHYDROGENASE ISOZYMES AND AGEING OF ERYTHROCYTES. Nature (1964) 0.84
[Fructose-1-phosphoaldolase activity of mammalian tissues. I. Distribution of fructose-1-phosphoaldolase activity in mammalian tissues]. Bull Soc Chim Biol (Paris) (1961) 0.84
[The outcome of essential polyglobulia treated with radioactive phosphorus. Apropos of a series of 310 cases]. Nouv Rev Fr Hematol (1961) 0.84
[PRESENT STATUS OF OUR EXPERIENCE WITH LIVER TRANSPLANTATION IN ANIMALS]. Mem Acad Chir (Paris) (1965) 0.83
NEW METHODS OF TREATMENT IN RADIATION THERAPY. Clin Radiol (1964) 0.83
[The penetration of iron in red cells in vitro]. C R Hebd Seances Acad Sci (1955) 0.83
[Characteristics of abnormal thyroglobulin extracted from certain congenital goiters with disorders of homonogenesis]. Rev Fr Etud Clin Biol (1959) 0.82
[Aldolase excess in blood in myopathic mice]. C R Hebd Seances Acad Sci (1957) 0.81
[Hyperaldolasemia, a biological sign of primary cancer of the liver]. Rev Fr Etud Clin Biol (1960) 0.80
[Effect of bleeding on erythropoiesis and iron metabolism in irradiated mice]. Rev Fr Etud Clin Biol (1959) 0.80
Total body irradiation for organ transplantation. Proc R Soc Med (1961) 0.79
[Treatment of thrombocythemia by radiophosphorus]. Sang (1957) 0.79
[SERUM CREATINE KINASE IN MYOPATHIC MICE]. Enzymol Biol Clin (Basel) (1963) 0.78
[Research on anemia in acute leukosis. I. Iron metabolism in acute leukosis studies with Fe59]. Rev Hematol (1954) 0.78
[TECHNIC OF STUDYING ERYTHROPOIESIS USING RADIOACTIVE IRON]. Rev Fr Etud Clin Biol (1965) 0.78
[Modification of erythropoiesis after pelvic radiotherapy]. Acta radiol (1959) 0.78
[Anemia in acute leukosis]. Sem Hop (1955) 0.77
[HEMATOLOGIC COURSE OF PATIENTS SUBJECTED TO TOTAL-BODY IRRADIATION FOR ORGAN TRANSPLANTATION]. Ann Radiol (Paris) (1963) 0.77
[Normal aldolase activity of cerebrospinal fluid]. Clin Chim Acta (1962) 0.76
[Hypothyroidism caused by a congenital abnormality in thyroxin synthesis]. Rev Fr Etud Clin Biol (1958) 0.76
[Action of radioactive phosphorus on essential polyglobulism and excessive number of platelets; 82 personal cases]. Presse Med (1955) 0.75
[Study of the distribution of radiophosphorus (P32) by the external measurement of deceleration radiations]. Rev Fr Etud Clin Biol (1958) 0.75
[Effect of intraperitoneal radioactive colloidal gold injection on the parenchyma of rat livers; induction of cholangiomas]. Bull Assoc Fr Etud Cancer (1955) 0.75
[Not Available]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Use of radioiodine 132 in thyroid function tests in children]. Minerva Nucl (1958) 0.75
[Use of radioactive isotopes in diagnosis and treatment of non-cancerous diseases]. Maroc Med (1955) 0.75
[Ionizing radiations in pneumological practice (radiodiagnosis & radiodetection)]. Bull Acad Natl Med (1958) 0.75
[Massive hepatic steatosis in an alcoholic; sudden fatal evolution]. Bull Mem Soc Med Hop Paris (1951) 0.75
[Results of 3000 thyroid function tests using radioactive iodine]. Minerva Nucl (1958) 0.75
[Decisive progress in telecurietherapy; telecobalttherapy]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Treatment of tumors of the lung and esophagus by betatron]. Minerva Nucl (1958) 0.75
[Physiopathologic studies on myeloid splenomegaly with myelofibrosis; studies with radioactive iron and chromium]. Rev Hematol (1958) 0.75
[Rapidity of renewal of the liver phosphatides in the rat subjected to a diet rich in cholesterol, continuous or interrupted]. C R Hebd Seances Acad Sci (1953) 0.75
[Examination of the thyroid by drilling puncture; measurement of radioactivity and autography of removed substance]. Ann Endocrinol (Paris) (1953) 0.75
[Sporadic goitrous cretinism caused by congenital abnormality in thyroid hormone synthesis; 2 case reports]. Sem Hop (1958) 0.75
[Three thousand radioiodine thyroid function tests]. Presse Med (1958) 0.75
[Use of radioactive isotopes in cancerology]. Maroc Med (1955) 0.75
[Atomic traumatism]. Rev Prat (1954) 0.75
[The therapeutic use of radioiodine]. Rev Prat (1958) 0.75
[Importance of transverse tomography (horizontal strata) in marking, centering and dosimetry of thoracic tumors treated by transcutaneous radiotherapy]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Variations in blood iron during the evolution of essential polyglobulism]. Bull Acad Natl Med (1952) 0.75
[Not Available]. Rev Fr Etud Clin Biol (1956) 0.75
[Generalities on medical and biological use of radioactive isotopes]. Maroc Med (1955) 0.75
[Effect of the selective irradiation of the spleen on Fe59 metabolism in rats]. C R Seances Soc Biol Fil (1956) 0.75
[Results of treatment of 43 cases of cancer of the thyroid with radioactive iodine]. J Radiol Electrol Arch Electr Medicale (1953) 0.75
[Movement of radiobromine in rabbit nervous system]. C R Seances Soc Biol Fil (1951) 0.75
[Comparative splenic lesions secondary to selective local irradiation of the spleen to total body irradiation with x-rays in rats]. C R Hebd Seances Acad Sci (1955) 0.75
[Measurement of erythrocyte formation in man using radioactive chromium]. Rev Hematol (1958) 0.75
[Radioactive iodine and the thyroid]. Rev Prat (1958) 0.75
[Centering procedures in deep radiotherapy by transcutaneous route]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Splenic lesions induced in the rat by segmental or global irradiation of the organism, or by selective irradiation of the spleen]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Practical problems of dosimetry. II. Role of diffusion in therapeutic use of radio-elements]. J Radiol Electrol Arch Electr Medicale (1956) 0.75
[Results of treatment of 115 cases of hyperthyroidism with radioactive iodine]. Presse Med (1953) 0.75
[Study of the distribution of radiophosphorus (P 32) by external measurement of Brehmstrahlung]. C R Hebd Seances Acad Sci (1958) 0.75
[Radioactive iodine in laboratory diagnosis]. Sem Hop (1953) 0.75
[Preliminary results of the treatment of neoplastic effusions with radioactive gold]. Bull Assoc Fr Etud Cancer (1953) 0.75
[Compensatory hyperfunctioning of the thyroid isthmus after double lobectomy]. C R Hebd Seances Acad Sci (1958) 0.75
[Not Available]. Bull Mem Soc Med Hop Paris (1948) 0.75
[New data concerning fatty degeneration of the liver]. J Physiol (Paris) (1953) 0.75
[Marking and centering procedures in transcutaneous deep radiotherapy]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Movement of radiobromine in the nervous system of the rabbit; study after perfusion]. C R Seances Soc Biol Fil (1951) 0.75
[Importance of high-energy radiotherapy, alone & with surgery, in the treatment of bronchial cancer]. Sem Hop (1958) 0.75
[Study of various aspects of metabolism of thyroxin in humans]. J Physiol (Paris) (1956) 0.75
[Immediate action of x-ray irradiation on the thyroid function of the rat]. C R Hebd Seances Acad Sci (1953) 0.75
[Study of 54 cases of cancer of the thoracic esophagus treated by betatron (22 MeV)]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Metabolism of radioiodine labeled thyroxin in man after injection of physiological and pharmacodynamic doses]. Ann Endocrinol (Paris) (1955) 0.75
[Comparison between 2 groups of cancers of thoracic esophagus treated by 200kV radiotherapy & high energy radiotherapy (betatron, 22 MeV)]. Arch Mal Appar Dig Mal Nutr (1959) 0.75
[Not Available]. Bull Assoc Fr Etud Cancer (1957) 0.75
[Nanism caused by incomplete hypothyroidism]. Bull Mem Soc Med Hop Paris (1956) 0.75
[Exploration of blood circulation in the sector spleen-splenic vein-liver]. Presse Med (1952) 0.75
[The progress of cancer therapy]. Lutte Cancer (1955) 0.75
[Radioactive phosphorus in chronic leukemias; first personal results in 24 cases]. J Radiol Electrol Arch Electr Medicale (1952) 0.75
[Not Available]. Rev Med Chir Mal Foie (1956) 0.75